Skip to content

Comparison of Retinal Damage in ICL Implantation Using 3D Visualization System vs. Microscope

Comparison of Ngenuity and Traditional Microscopy in Assessing Retinal Function Recovery Post-ICL Surgery

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06966622
Enrollment
40
Registered
2025-05-13
Start date
2025-08-25
Completion date
2026-05-31
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Myopia

Brief summary

Implantable collamer lens (ICL) implantation is considered one of the most effective surgical treatments for high myopia. The procedure primarily involves adjusting the position of the ICL within the eye. However, precise calculation of the ICL optical power may cause the surgical light source to remain focused on the macular area during this process, potentially leading to iatrogenic light-induced damage. Theoretically, the combination of a 3D visualization surgical system and coaxial illumination technology can reduce the illumination intensity and decrease iatrogenic light damage. This study aims to compare the retinal physiological changes in patients undergoing ICL surgery through 3D visualization surgical system with coaxial illumination versus a traditional microscope with standard illumination.

Interventions

PROCEDURE3D visualization system with coaxial illumination

operation through 3D visualization system with coaxial illumination

PROCEDUREmicroscope with standard illumination

operation through microscope with standard illumination

Sponsors

Alcon Research
CollaboratorINDUSTRY
Fuzhou Eye Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of high myopic * Aged 18-40 years * Desire to improve their refractive status via ICL surgery * Relatively stable refractive error (change ≤ 0.50 D per year for two consecutive years) * Central anterior chamber depth ≥ 2.8 mm * Open angles * Corneal endothelial cell density ≥ 2000 cells/mm2.

Exclusion criteria

* Cataracts * Corneal diseases, * Glaucoma, * Nystagmus, * Strabismus, * Lens subluxation, * Severe vitreoretinal diseases, * Other ocular diseases * A history of ocular trauma * A history of ocular surgery

Design outcomes

Primary

MeasureTime frame
b-wave amplitude1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op

Secondary

MeasureTime frame
a-wave amplitude1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
macular vessel density1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
Uncorrected visual acuity1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op
Best-corrected visual acuity1 day pre-op; 1 day post-op; 7 days post-op; 30 days post-op

Other

MeasureTime frame
Intraoperative illumination intensitysurgery beginning
Surgical timeStarting with the making of the surgical incision and ending with incision closure

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026